These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27453120)

  • 21. Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment?--yes.
    Roder DM; Olver IN
    Med J Aust; 2012 Jan; 196(1):16. PubMed ID: 22256917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Breast Cancer Risk Predictive Models and Screening Strategies for Chinese Women.
    Zhao Y; Xiong P; McCullough LE; Miller EE; Li H; Huang Y; Zhao M; Wang MJ; Kang M; Wang Q; Li JY
    J Womens Health (Larchmt); 2017 Mar; 26(3):294-302. PubMed ID: 28263689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening Mammography in Women 40-49 Years Old: Current Evidence.
    Ray KM; Joe BN; Freimanis RI; Sickles EA; Hendrick RE
    AJR Am J Roentgenol; 2018 Feb; 210(2):264-270. PubMed ID: 29064760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
    van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
    J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EMAS position statement: individualized breast cancer screening versus population-based mammography screening programmes.
    Depypere H; Desreux J; Pérez-López FR; Ceausu I; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; van der Schouw YT; Simoncini T; Tremollieres F; Rees M; EMAS
    Maturitas; 2014 Dec; 79(4):481-6. PubMed ID: 25277123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancers detected in only one of two arms of a tomosynthesis (3D-mammography) population screening trial (STORM-2).
    Bernardi D; Houssami N
    Breast; 2017 Apr; 32():98-101. PubMed ID: 28107735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
    Broeders M; Paci E
    Womens Health (Lond); 2015 Nov; 11(6):883-90. PubMed ID: 26619214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controversies in breast cancer screening for women aged 40-49 years.
    Suzuki A; Ishida T; Ohuchi N
    Jpn J Clin Oncol; 2014 Jul; 44(7):613-8. PubMed ID: 24821976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast Cancer Screening and Optimizing Recommendations.
    Lancaster RB; Gulla S; De Los Santos J; Umphrey H
    Semin Roentgenol; 2018 Oct; 53(4):280-293. PubMed ID: 30449346
    [No Abstract]   [Full Text] [Related]  

  • 30. Contribution of clinical breast examination to mammography screening in the early detection of breast cancer.
    Bancej C; Decker K; Chiarelli A; Harrison M; Turner D; Brisson J
    J Med Screen; 2003; 10(1):16-21. PubMed ID: 12790311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging and breast ultrasonography as an adjunct to mammographic screening in high-risk patients.
    Le-Petross HT; Shetty MK
    Semin Ultrasound CT MR; 2011 Aug; 32(4):266-72. PubMed ID: 21782116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Women aged 75 years and older benefit from mammography.
    Printz C
    Cancer; 2015 Jan; 121(2):165. PubMed ID: 25581117
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor Doubling Time and Screening Interval.
    Bhatt AA; Niell B
    Radiol Clin North Am; 2024 Jul; 62(4):571-580. PubMed ID: 38777534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study.
    Morrell S; Taylor R; Roder D; Dobson A
    J Med Screen; 2012 Mar; 19(1):26-34. PubMed ID: 22345322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cumulative risk of cancer detection in breast cancer screening by protocol strategy.
    Blanch J; Sala M; Román M; Ederra M; Salas D; Zubizarreta R; Sanchez M; Rué M; Castells X;
    Breast Cancer Res Treat; 2013 Apr; 138(3):869-77. PubMed ID: 23471648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Issues in the Overdiagnosis and Overtreatment of Breast Cancer.
    Monticciolo DL; Helvie MA; Hendrick RE
    AJR Am J Roentgenol; 2018 Feb; 210(2):285-291. PubMed ID: 29091010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer detection using single-reading of breast tomosynthesis (3D-mammography) compared to double-reading of 2D-mammography: Evidence from a population-based trial.
    Houssami N; Bernardi D; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Macaskill P
    Cancer Epidemiol; 2017 Apr; 47():94-99. PubMed ID: 28192742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fake facts and alternative truths in medical research.
    Hofmann B
    BMC Med Ethics; 2018 Jan; 19(1):4. PubMed ID: 29374485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The other side of technology: risk of overdiagnosis of breast cancer with mammography screening.
    Puliti D; Paci E
    Future Oncol; 2009 May; 5(4):481-91. PubMed ID: 19450177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.